Abstract:The juvenile form of neuronal ceroid Lipofuscinosis (JNCL) is the most common form within this group of rare lysosomal storage disorders, causing pediatric neurodegeneration. The genetic disorder, which is caused by recessive mutations affecting the CLN3 gene, features progressive vision loss, cognitive and motor decline and other psychiatric conditions, seizure episodes, leading to premature death. Animal models have traditionally aid the understanding of the disease mechanisms and pathology and are very relevant for biomarker research and therapeutic testing. Nevertheless, there is a need for establishing reliable and predictive human cellular models to study the disease. Since patient material, particularly from children, is scarce and difficult to obtain, we generated an engineered a CLN3-mutant isogenic human induced pluripotent stem cell (hiPSC) line carrying the c.1054C → T pathologic variant, using state of the art CRISPR/Cas9 technology. To prove the suitability of the isogenic pair to model JNCL, we screened for disease-specific phenotypes in non-neuronal two-dimensional cell culture models as well as in cerebral brain organoids. Our data demonstrates that the sole introduction of the pathogenic variant gives rise to classical hallmarks of JNCL in vitro. Additionally, we discovered an alteration of the splicing caused by this particular mutation. Next, we derived cerebral organoids and used them as a neurodevelopmental model to study the particular effects of the CLN3Q352X mutation during brain formation in the disease context. About half of the mutation -carrying cerebral organoids completely failed to develop normally. The other half, which escaped this severe defect were used for the analysis of more subtle alterations. In these escapers, whole-transcriptome analysis demonstrated early disease signatures, affecting pathways related to development, corticogenesis and synapses. Complementary metabolomics analysis confirmed decreased levels of cerebral tissue metabolites, some particularly relevant for synapse formation and neurotransmission, such as gamma-amino butyric acid (GABA). Our data suggests that a mutation in CLN3 severely affects brain development. Furthermore, before disease onset, disease -associated neurodevelopmental changes, particular concerning synapse formation and function, occur.

Unraveling LIS1-Lissencephaly: Insights from Cerebral Organoids Suggest Severity- Dependent Genotype-Phenotype Correlations, Molecular Mechanisms and Therapeutic Strategies

Multiple dose-dependent effects of Lis1 on cerebral cortical development

[Molecular genetics of lissencephaly and microcephaly]

Brain Pathways in LIS1-Associated Lissencephaly Revealed by Diffusion MRI Tractography

Multiplex Consanguineous Family Highlights CLASP1 as a Candidate Gene for Lissencephaly

Altered Extracellular Matrix Structure and Elevated Stiffness in a Brain Organoid Model for Disease

Causal heterogeneity in isolated lissencephaly

Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome

An in vitro model of lissencephaly: expanding the role of DCX during neurogenesis

Increased LIS1 Expression Affects Human and Mouse Brain Development

Characterization of the Epileptogenic Phenotype and Response to Antiseizure Medications in Lissencephaly Patients

Lis1-Nde1-dependent neuronal fate control determines cerebral cortical size and lamination

Increased LIS1 expression affects human and mouse brain development (Reprinted from Nature Gentics, vol 41, pgs 168-177, 2008)

Human iPSC-derived cerebral organoids model features of Leigh syndrome and reveal abnormal corticogenesis

Novel lissencephaly-associated NDEL1 variant reveals distinct roles of NDE1 and NDEL1 in nucleokinesis and human cortical malformations

Modeling Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids using microglia-sufficient brain organoids

Enhanced Notch dependent gliogenesis and delayed physiological maturation underlie neurodevelopmental defects in Lowe syndrome

Isolated Lissencephaly: Report of Four Patients From Two Unrelated Families

A variant suggests a phenotypic relation with lissencephaly in humans

Structures of human dynein in complex with the lissencephaly 1 protein, LIS1

Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis